How the consultation process works at a UK online weight loss clinic

Completing your health questionnaire

Most reputable UK online weight management services begin with a structured medical questionnaire. You will be asked about your BMI, medical history, current medications, allergies, previous weight loss attempts, and any conditions that affect your eligibility. These questions follow NICE clinical guidance and the prescribing requirements for prescription-only medicines, so the process is thorough by design.

This is not a rubber stamp. Under GPhC guidance updated in 2025 and 2026, prescribers must independently verify clinical details – self-reported figures alone are no longer sufficient for higher-risk medicines such as GLP-1 injections. Have accurate height and weight measurements, a current medication list, and any relevant diagnoses ready before you begin.

How a UK prescriber reviews your application

Once submitted, your questionnaire is assigned to a UK-registered clinician – a doctor, nurse independent prescriber, or pharmacist independent prescriber – who assesses your responses individually. If your application meets the clinical criteria and it is appropriate to prescribe, they will issue a prescription. When the prescriber requires more information from you, they will contact you directly to request it, before proceeding with your order. And if treatment is not appropriate, you will receive a full refund.

One thing patients at Dr Weightmans consistently comment on is how quickly this happens. It is not uncommon for a patient to submit their questionnaire at 1pm and have their medication on the doorstep the following morning – provided everything required is submitted correctly first time. That speed comes from a clinical team that works to a clear standard: no orders are left unattended at the end of the day. Everything is either processed or responded to.

Prescription weight loss medications available from a UK online weight loss clinic

GLP-1 injections: Wegovy and Mounjaro

GLP-1 receptor agonists work by reducing appetite, improving feelings of fullness, and slowing stomach emptying – all of which lower calorie intake and support steady, clinically meaningful weight loss. When combined with changes to nutrition and physical activity, they consistently outperform non-pharmacological approaches over the first year of treatment.

Two options are currently available privately in the UK. Wegovy (semaglutide) produced around 15% average body weight reduction at 68 weeks in clinical trials involving adults with obesity or overweight and associated conditions. Mounjaro (tirzepatide), which acts on both GLP-1 and GIP receptors, demonstrated approximately 20 to 22.5% weight reduction over similar timeframes in comparable trials. Both are prescription-only medicines.

What’s coming next in medical weight management

The GLP-1 market is evolving quickly. Oral GLP-1 tablets are expected to become available later in 2026, which will open up treatment to patients who are uncomfortable with or unsuitable for weekly injections. Further along in development, drugs such as retatrutide – a triple-receptor agonist currently in clinical trials – have shown even greater efficacy than current options. The pipeline is active, and the clinical landscape for medical weight management in the UK will look significantly different within two to three years.

Other prescription options for weight management

Not everyone is eligible or suited to weekly GLP-1 injections. Saxenda (daily liraglutide) is an established injectable alternative used in certain clinical situations. Orlistat, a capsule that reduces dietary fat absorption, remains an option where injectables are not indicated or preferred. Each medicine carries a distinct side-effect and efficacy profile that a prescriber will weigh against your individual circumstances before recommending anything.

How your prescription gets dispensed and delivered

The GPhC-registered pharmacy dispensing process

Once a prescription is approved, it is sent directly to the pharmacy, where it is dispensed, clinically checked by a pharmacist, packaged, and sent out with a courier for delivery – all in discreet packaging, so nothing about the contents is visible from the outside.

GPhC registration confirms that the pharmacy premises are inspected, that medicines are sourced from licensed wholesalers, and that controlled processes cover storage, dispensing, and verification. Always check a provider’s GPhC premises number on the public register at pharmacyregulation.org before purchasing. If you cannot locate it, do not proceed with that provider.

Cold-chain delivery: what actually happens

GLP-1 injectable pens must be kept refrigerated from manufacture to your fridge. At Dr Weightmans, when medication arrives at the pharmacy from the supplier, it is stored immediately under refrigeration. At the point of dispensing, it is packed in industry-standard insulated woolpack with an ice pack, placed into a cardboard box for additional protection, and sealed in a mailer bag before being handed to the courier.

This layered approach is designed to maintain the cold chain even if there are delays in transit. If a provider cannot clearly explain their cold-chain process, that is reason enough to look elsewhere.

What arrives at your door

• ✓ Medication and a personalised dosing guide matched to your starting dose
• ✓ Sharps disposal information and a return or replacement plan for bins
• ✓ Contact details for your clinical team for queries and check-ins
• ✓ Discreet outer packaging with no identifying information about the contents

What ongoing support actually looks like

Dose reviews and how titration is managed

GLP-1 treatment is not a set-and-forget arrangement, and how doses are managed over time is one of the areas where providers differ most significantly.

At Dr Weightmans, every re-order triggers a clinical review. Before a patient can reorder, they complete a dedicated re-order form covering how the previous month’s treatment has gone, whether they experienced any side effects, and whether anything has changed in their health. The prescriber then reviews this and contacts the patient – through a personal account chat function, by telephone, or by email – before any prescription is issued.

Under normal circumstances, dosing increases naturally each month during the titration phase: month one at 2.5mg, month two at 5mg, and so on. But the prescriber adapts to what the patient is actually experiencing:

• If there has been a gap in treatment, the prescriber will recommend dropping back to a lower dose to avoid side effects returning.
• If side effects are present, the dose stays the same or is reduced.
• If a patient has been tolerating a dose well but has plateaued without losing weight, the prescriber may recommend stepping up sooner.

This kind of active, individualised management is a medical requirement – not an optional extra. Any provider that ships repeat supplies without conducting a clinical review first should be treated as a serious red flag.

Managing side effects with clinical backup

The most common side effects with GLP-1 medicines are nausea, vomiting, constipation, bloating, and fatigue. These tend to be most noticeable in the early weeks or following a dose increase – and in practice, they are most commonly seen in patients who have moved up doses too quickly, keen to accelerate their progress.

The clinical approach at Dr Weightmans is to find the highest dose a patient can tolerate while still losing weight, rather than pushing to the maximum dose regardless. Alongside that, patients are advised to stay well hydrated and are recommended rehydration salts to help ease gastrointestinal side effects – a simple, practical measure that makes a meaningful difference and that many patients are not aware of when they start.

How to check whether a UK online weight loss clinic is safe and regulated

Verifying GPhC registration and prescriber credentials

Before handing over payment or medical data, carry out a basic compliance check. Official registers are free and take only a few minutes.

1. Find the pharmacy premises registration number on the provider’s website and search it on the GPhC register at pharmacyregulation.org.
2. Confirm the prescriber’s professional registration on the GMC (doctors), NMC (nurses), or GPhC (pharmacist prescribers) public registers.
3. If the service provides regulated clinical care beyond dispensing, look for CQC registration and review the provider’s inspection history.

Screenshots of compliance badges are not sufficient. Use the public registers directly and match names, addresses, and registration numbers exactly.

Warning signs of unregulated providers

The biggest risk for patients in the current UK market is purchasing unregulated, unlicensed, and in some cases counterfeit products through unregulated online channels or social media. The MHRA has continued enforcement action against such sites through 2025 and 2026.

Beyond outright counterfeit products, there are subtler warning signs within the regulated market itself. Patients who have had poor experiences elsewhere frequently report the same pattern: little or no communication after ordering, medication not arriving for days despite ordering in advance, prices increasing sharply after the first discounted order, pressure to join subscription models, or being pushed to recruit others through affiliate schemes in exchange for better pricing.

This pricing behaviour in particular causes a real clinical problem. When patients are not confident about consistent supply or future pricing, they stockpile medication at the same dose rather than following their prescriber’s titration plan – which undermines the entire clinical process.

• No consultation before purchase, or a checkout that asks no clinical questions
• No named UK-registered prescriber and no GPhC premises number displayed
• Prices that drop heavily for the first order then increase significantly on renewal
• No clinical review or dose assessment before repeat orders are dispatched
• Pressure to recruit others or join affiliate referral schemes

NHS digital weight management vs a private UK online weight loss clinic

Who qualifies for free NHS support

The NHS Digital Weight Management Programme is a free 12-week online course available to adults in England. Eligibility requires a BMI above 30 (or above 27.5 for some ethnic backgrounds) combined with a diagnosis of type 2 diabetes or high blood pressure, plus a referral from a GP or local pharmacy. The programme covers nutrition, physical activity, and behaviour change, but does not include prescription medicines. For many people, it is the right starting point and worth exploring before considering private options.

When a private clinic fills the gap

There are three situations where a private online weight loss clinic is typically the more practical route.

The NHS threshold is substantially higher than the clinical licence for the medication. To access Mounjaro through NHS specialist services currently requires a BMI above 40, or above 37.5 with weight-related conditions. The clinical indication for the medication – and the threshold used by regulated private providers – starts at BMI 30, or 27.5 with weight-related conditions. Many people who are clinically appropriate candidates for treatment simply do not qualify under current NHS criteria.

Access to NHS specialist services is not straightforward even for those who qualify. Referral pathways are limited and waiting lists are lengthy across most regions of England.

Many people prefer the privacy of an online consultation. This is something that comes up regularly in practice – people feel more comfortable discussing their weight confidentially, online, with qualified professionals they do not personally know and do not have to see face to face. That is a legitimate preference, and a well-run private service supports it well.

At Dr Weightmans, pricing is consistent from the first order onwards. There are no heavily discounted introductory offers followed by significant price increases – because that model creates exactly the kind of patient behaviour (stockpiling, provider-hopping, inconsistent titration) that works against good clinical outcomes. Our prescribers are accredited to all required standards, and while we are best known for weight management, our specialist prescribers support a growing range of conditions through the same straightforward, clinically rigorous process.

Summary: what to look for in a UK online weight loss clinic

• A structured medical consultation before any prescription is issued
• Prescribing only when you meet clinical criteria, with a full refund if not
• Dispensing through a GPhC-registered pharmacy – verifiable on the public register
• Cold-chain delivery that maintains refrigeration from pharmacy to your door
• A clinical review triggered by every re-order, not just the first
• Individualised dose management based on your actual experience, not a fixed schedule
• Transparent, consistent pricing with no sharp post-introductory increases
• Direct access to clinicians throughout your treatment